IDNK: A Potential Drug Target Or Biomarker for Cancer (G414328)

Target Name: IDNK

NCBI ID: G414328

IDNK

IDNK: A Potential Drug Target Or Biomarker for Cancer

IDNK (Integrated DNANK gene) is a gene located on chromosome 16 that has been identified as a potential drug target or biomarker for various diseases, including cancer. The IDNK gene is involved in the immune response and has been shown to play a role in regulating cell death and apoptosis, which are important processes that are often disrupted in cancer cells.

Research has shown that IDNK is expressed in a wide range of tissues and cells, including tissues from cancer-prone organs such as the colon, lung, and breast. It is also highly expressed in human placenta, which is a critical organ that supports the growth and development of fetuses. This suggests that IDNK may be an important biomarker for cancer, as it may be present in the placenta, which is often the site of cancer recurrence.

IDNK has also been shown to play a role in cell death and apoptosis, which are processes that are often disrupted in cancer cells. In fact, studies have shown that IDNK is often overexpressed in cancer cells, which may contribute to their ability to evade the immune system and continue to grow and multiply.

Another study has shown that IDNK is expressed in the brain and that it is involved in the regulation of neurodegenerative diseases. This suggests that IDNK may be an important target for drugs that are being developed to treat these conditions.

IDNK has also been shown to play a role in the regulation of inflammation. Studies have shown that IDNK is involved in the production of pro-inflammatory cytokines, which can contribute to inflammation and tissue damage. This suggests that IDNK may be an important target for drugs that are being developed to treat inflammatory diseases.

In conclusion, IDNK is a gene that has been shown to play a role in the immune response, cell death and apoptosis, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of IDNK in cancer and other diseases, and to identify potential drugs that can target it effectively.

Protein Name: IDNK Gluconokinase

The "IDNK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IDNK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets